financetom
Business
financetom
/
Business
/
T-mobile Us Insider Sold Shares Worth $24,673,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
T-mobile Us Insider Sold Shares Worth $24,673,000, According to a Recent SEC Filing
Nov 9, 2024 11:45 AM

05:43 PM EST, 11/06/2024 (MT Newswires) -- Raul Marcelo Claure, Director, on November 04, 2024, sold 110,000 shares in T-mobile Us ( TMUS ) for $24,673,000. Following the Form 4 filing with the SEC, Claure has control over a total of 3,288,583 shares of the company, with 1,847,379 shares held directly and 1,441,204 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1283699/000128369924000147/xslF345X05/wk-form4_1730932526.xml

Price: 232.64, Change: +0.45, Percent Change: +0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Nov 17, 2025
02:46 PM EST, 11/17/2025 (MT Newswires) -- Target ( TGT ) is likely to post soft Q3 on Wednesday with comparable sales down about 2% and could narrow its fiscal 2025 earnings per share guidance toward the low end of its $7 to $9 range, Oppenheimer said Monday in a pre-results report. Oppenheimer said it added conservatism to its Q4...
Novo Nordisk Owner to Reportedly Sell 7.8% Stake in UK's ConvaTec
Novo Nordisk Owner to Reportedly Sell 7.8% Stake in UK's ConvaTec
Nov 17, 2025
03:01 PM EST, 11/17/2025 (MT Newswires) -- Novo Nordisk's ( NVO ) owner, Novo Holdings, is set to sell its 7.8% stake in UK-based medical products company ConvaTec Group, multiple news outlets reported Monday. The company is offering about 155 million shares in an overnight placing with investors, with the deal expected to price at 2.27 British pounds ($2.99) per...
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Nov 17, 2025
03:04 PM EST, 11/17/2025 (MT Newswires) -- Liberty Defense Holdings ( LDDFF ) shares were up near 14% on Monday after it received a competitive bid award for three HEXWAVE walkthrough screening systems at a U.S. State Capitol complex in the Northeast. The company said the systems will support security screening for officials, employees, and visitors across two high-traffic buildings....
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Nov 17, 2025
Jazz Pharmaceuticals Plc ( JAZZ ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). What Happened: When compared to the control group that received trastuzumab...
Copyright 2023-2026 - www.financetom.com All Rights Reserved